Valvular & structural heart diseaseCohort study

Tricuspid regurgitation and outcomes in mitral valve transcatheter edge-to-edge repair

Eur Heart JPublished

  • Registry-based cohort study

Authors' conclusion

Post-procedural TR, but not baseline TR, was associated with outcomes after M-TEER.

Study context

Population
Patients undergoing mitral transcatheter edge-to-edge repair (M-TEER) in the OCEAN-Mitral registry; significant tricuspid regurgitation (TR) = TR ≥ moderate
Participants
2,103 / 201 / 504 / 858
Exposure
TR status before/after M-TEER: new-onset, residual or normalized TR vs no TR
  • no TRn = 2,103reference
  • new-onset TRn = 201
  • normalized TRn = 504
  • residual TRn = 858
Outcome
CV death or HF hospitalization

Main finding

As reported in the abstract

CV death or HF hospitalization (adjusted)
Each group vs no TRHazard ratio (95% CI)
new-onset TR
1.83(1.39–2.40)
residual TR
1.45(1.23–1.72)
normalized TR
0.82(0.65–1.04)

Observational data: associations, not effects.

Further findings

Baseline TR and TR pressure gradient

Baseline TR and TR pressure gradient not associated with outcomes after M-TEER

Change in TR pressure gradient from baseline to post-procedure

TR pressure gradient changes associated with subsequent outcomes after M-TEER

Factors associated with new-onset and residual TR

Commonly associated with dilated tricuspid annulus diameter and AF

Original publication

Tricuspid regurgitation and outcomes in mitral valve transcatheter edge-to-edge repair. Eur Heart J. Published 28 January 2025. doi:10.1093/eurheartj/ehae924

Summarised from the published abstract; every number is checked against it